---
title: 'Functional cure and long-term survival in multiple myeloma: how to challenge
  the previously impossible'
date: '2024-02-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38356448/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240215170609&v=2.18.0
source: heidelberg[Affiliation]
description: Multiple myeloma (MM) is a heterogeneous disease with survival ranging
  from months to decades. The goal of 'cure' remains elusive for most patients, but
  has been shown to be possible, with durable remission and a transition to a plateau
  phase (analogous to monoclonal gammopathy of uncertain significance/smoldering Myeloma
  (MGUS/SMM)). Two representative cases set the stage to illustrate how this might
  be possible and what still needs to be determined to achieve functional disease
  control over ...
disable_comments: true
---
Multiple myeloma (MM) is a heterogeneous disease with survival ranging from months to decades. The goal of 'cure' remains elusive for most patients, but has been shown to be possible, with durable remission and a transition to a plateau phase (analogous to monoclonal gammopathy of uncertain significance/smoldering Myeloma (MGUS/SMM)). Two representative cases set the stage to illustrate how this might be possible and what still needs to be determined to achieve functional disease control over ...